MR1011C Modification of the OIQoL-P
Research type
Research Study
Full title
MR1011C Modification of the OIQoL-P
IRAS ID
273248
Contact name
Helen Doll
Contact email
Sponsor organisation
Mereo Biopharma
Duration of Study in the UK
0 years, 3 months, 30 days
Research summary
The purpose of conducting this participant research is to explore the patient and caregiver journey of Osteogensis Imperfecta (OI) or Brittle Bone Disease.
Approximately 24 participants (a mixture of parent/carers and patients/children aged 5-17 diagnosed with OI) will take part in a 60 minute Face to Face or web-assisted telephone interviews to understand the impact of OI on quality of life measures. Children with OI and their parents will be asked to discuss the symptoms and impacts of OI, and children and adolescents and their parents/caregivers will be asked to complete the OIQoL-P/OIQoL-O and queried about their understanding of the measure, its relevance, recall period, and whether they would make any changes to the tool. Parent/carers will also be asked to complete demographics form for both themselves and their child.
REC name
North West - Liverpool Central Research Ethics Committee
REC reference
19/NW/0654
Date of REC Opinion
29 Nov 2019
REC opinion
Further Information Favourable Opinion